Lexicon Stock Performance


USD 2.13  0.09  4.05%   

The company secures a Beta (Market Risk) of 1.6791, which conveys a somewhat significant risk relative to the market. Let's try to break down what Lexicon's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lexicon Pharmaceutcl will likely underperform. Even though it is essential to pay attention to Lexicon Pharmaceutcl price patterns, it is always good to be careful when utilizing equity historical price patterns. Our philosophy towards estimating any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Lexicon Pharmaceutcl exposes twenty-one different technical indicators, which can help you to evaluate its performance. Lexicon Pharmaceutcl has an expected return of -0.33%. Please be advised to verify Lexicon Pharmaceutcl jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Lexicon Pharmaceutcl performance from the past will be repeated at some point in the near future.
Lexicon Performance
0 of 100
Over the last 90 days Lexicon Pharmaceutcl has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2022. The current disturbance may also be a sign of long term up-swing for the company investors. ...more

Structure and Payout Changes

Last Split Factor
Last Split Date

Lexicon Price Channel

Quick Ratio7.39
Fifty Two Week Low1.3100
Target High Price16.00
Fifty Two Week High5.2200
Target Low Price10.00

Lexicon Pharmaceutcl Relative Risk vs. Return Landscape

If you would invest  276.00  in Lexicon Pharmaceutcl on August 29, 2022 and sell it today you would lose (63.00)  from holding Lexicon Pharmaceutcl or give up 22.83% of portfolio value over 90 days. Lexicon Pharmaceutcl is currently does not generate positive expected returns and assumes 3.9123% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Lexicon, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Lexicon Pharmaceutcl is expected to under-perform the market. In addition to that, the company is 2.85 times more volatile than its market benchmark. It trades about -0.08 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.08 per unit of volatility.

Lexicon Pharmaceutcl Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Lexicon Pharmaceutcl's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Lexicon Pharmaceutcl, and traders can use it to determine the average amount a Lexicon Pharmaceutcl's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0843

Good Returns
Average Returns
Small Returns
Negative ReturnsLXRX
Estimated Market Risk
  actual daily
 33 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Lexicon Pharmaceutcl is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lexicon Pharmaceutcl by adding it to a well-diversified portfolio.

About Lexicon Pharmaceutcl Performance

To evaluate Lexicon Pharmaceutcl Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Lexicon Pharmaceutcl generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Lexicon Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Lexicon Pharmaceutcl market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Lexicon's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(61.85) (66.73) 
Return on Average Assets(51.52) (52.87) 
Return on Average Equity(65.01) (70.14) 
Return on Invested Capital(5.88) (6.04) 
Return on Sales(291.80) (299.48) 

Things to note about Lexicon Pharmaceutcl

Checking the ongoing alerts about Lexicon Pharmaceutcl for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lexicon Pharmaceutcl help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Lexicon Pharmaceutcl Alerts

Equity Alerts and Improvement Suggestions

Lexicon Pharmaceutcl generated a negative expected return over the last 90 days
Lexicon Pharmaceutcl has high historical volatility and very poor performance
The company reported the previous year's revenue of 125 K. Net Loss for the year was (97.06 M) with loss before overhead, payroll, taxes, and interest of (54.75 M).
Lexicon Pharmaceutcl currently holds about 136.2 M in cash with (90.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72.
Over 82.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: The Global Clinical Diagnostics Market is expected to Surge at a CAGR of 7.02 percent During the Forecast Period DelveInsight - Yahoo Finance
Additionally, see Correlation Analysis. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for analysis

When running Lexicon Pharmaceutcl price analysis, check to measure Lexicon Pharmaceutcl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceutcl is operating at the current time. Most of Lexicon Pharmaceutcl's value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceutcl's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lexicon Pharmaceutcl's price. Additionally, you may evaluate how the addition of Lexicon Pharmaceutcl to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is Lexicon Pharmaceutcl's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexicon Pharmaceutcl. If investors know Lexicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexicon Pharmaceutcl listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
402 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Lexicon Pharmaceutcl is measured differently than its book value, which is the value of Lexicon that is recorded on the company's balance sheet. Investors also form their own opinion of Lexicon Pharmaceutcl's value that differs from its market value or its book value, called intrinsic value, which is Lexicon Pharmaceutcl's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexicon Pharmaceutcl's market value can be influenced by many factors that don't directly affect Lexicon Pharmaceutcl's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexicon Pharmaceutcl's value and its price as these two are different measures arrived at by different means. Investors typically determine Lexicon Pharmaceutcl value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexicon Pharmaceutcl's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.